KCM
BSX icon

Kingdon Capital Management’s Boston Scientific BSX Stock Holding History

Kingdon Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-531,813
Closed -$22.9M – 66
2019
Q2 		$22.9M Sell
531,813
-30,828
-5% -$1.19M 2.25% 14
2019
Q1 		$21.6M Buy
+562,641
New +$21.5M 2.89% 13
2017
Q4 		– Sell
-291,717
Closed -$8.51M – 115
2017
Q3 		$8.51M Buy
+291,717
New +$8.06M 0.55% 60

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Kingdon Capital Management's BSX Position: Q3 2019 in Review

Kingdon Capital Management sold out of Boston Scientific (BSX) in Q3 2019, closing a stake of 531,813 shares — an estimated $22.9M sold.

Kingdon Capital Management first reported a position in BSX in Q3 2017 and held it in 3 quarters. The position peaked at $22.9M in Q2 2019. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Kingdon Capital Management reported no remaining Boston Scientific position as of Q3 2019 after selling out during the quarter.
  • Kingdon Capital Management sold 531,813 Boston Scientific shares in Q3 2019, an estimated $22.9M.
  • Kingdon Capital Management first reported a position in Boston Scientific in Q3 2017 and held it in 3 quarters.
  • Kingdon Capital Management's Boston Scientific position peaked at $22.9M in Q2 2019.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Kingdon Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.